Frontier Wealth Management’s Novavax NVAX Stock Holding History

Frontier Wealth Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,050	Closed	-$229K	–	396
2020 Q4	$229K	Hold	2,050	–	–	0.02%	336
2020 Q3	$222K	Buy	+2,050	New	+$250K	0.02%	325
2019 Q1	–	Sell	-700	Closed	-$26K	–	377
2018 Q4	$26K	Buy	+700	New	+$27.1K	﹤0.01%	359
2016 Q3	–	Sell	-503	Closed	-$73K	–	372
2016 Q2	$73K	Buy	+503	New	+$57.6K	0.01%	324

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Frontier Wealth Management's NVAX Position: Q1 2021 in Review

Frontier Wealth Management sold out of Novavax (NVAX) in Q1 2021, closing a stake of 2,050 shares — an estimated $229K sold.

Frontier Wealth Management first reported a position in NVAX in Q2 2016 and held it in 4 quarters. The position peaked at $229K in Q4 2020. 389 funds tracked by Wall St. Rank hold NVAX as of Q1 2021.

Frontier Wealth Management reported no remaining Novavax position as of Q1 2021 after selling out during the quarter.
Frontier Wealth Management sold 2,050 Novavax shares in Q1 2021, an estimated $229K.
Frontier Wealth Management first reported a position in Novavax in Q2 2016 and held it in 4 quarters.
Frontier Wealth Management's Novavax position peaked at $229K in Q4 2020.
389 funds tracked by Wall St. Rank held Novavax as of Q1 2021.

Based on Frontier Wealth Management's 13F filing for Q1 2021, filed 17 May 2021.